Delivery Order SPE2DB24D1205-SPE2DB24FCTNU
Award Date
8/9/24
Potential Completion Date
8/12/24
Potential Value
$3.5K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of Vyvanse 50 mg capsules to the U.S. government. The $1,116.46 contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 with the DLA Troop Support Medical, which serves as the primary vehicle for Amerisourcebergen to supply a comprehensive range of...
This federal contract award is for the delivery of Vyvanse 50 mg capsules to the U.S. government. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The award, valued at $1,402.14, is a delivery order placed under Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA, valued at up to $999,999,999.00 through December 2025. This IDC serves as the primary vehicle for...
This federal contract award is for the delivery of Vyvanse 30 mg capsules in 100-count packages to the Defense Logistics Agency (DLA). The $9,748.40 firm-fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on October 21, 2024, with an ultimate completion date of October 22, 2024. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with...
This federal contract award is for the delivery of Vyvanse 40mg capsules to the Defense Logistics Agency (DLA), a defense agency. The prime contractor is AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through November 2026. This IDC enables the efficient procurement of a broad range of pharmaceutical products and medical supplies to...
This federal contract award is for the delivery of Vyvanse 30mg capsules in lots of 100 to the Medical Supply Chain division of the Defense Logistics Agency (DLA). The contract, valued at $3,473.83, was awarded to AmerisourceBergen Drug Corporation's Corporate Office division, a major pharmaceutical distributor. The award is a delivery order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which has a ceiling value of up to $999,999,999 through December 2025....
The federal contract award is for the delivery of Vyvanse capsules, 30mg, to the Defense Logistics Agency (DLA). The $16,721.57 fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of June 4, 2025 and is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This federal contract award is for the delivery of Vyvanse 50 mg capsules in quantities of 100s to the Defense Logistics Agency (DLA), a defense agency. The contract has a firm fixed price of $4,448.03 and a completion date of May 20, 2025. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. This appears to be a delivery order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999.00 that Amerisourcebergen...
This federal contract award is for the delivery of Vyvanse (lisdexamfetamine dimesylate) 50 mg capsules in 100-count packages to the U.S. Defense Logistics Agency (DLA). The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on August 23, 2024, with a completion date of August 26, 2024. The contract has a firm fixed price of $1,706.30 and is a delivery order under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which is valued...
This federal contract award is for the delivery of Vyvanse 30 mg capsules (100s) to the Defense Logistics Agency (DLA), a defense agency under the Department of Defense. The $3,530.51 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on March 17, 2025 with a completion date of March 18, 2025. The contract is not designated with a set-aside requirement, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite...
This federal contract award is for the delivery of Vyvanse 50 mg capsules to the Defense Logistics Agency (DLA), a defense agency. The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on March 24, 2025 for a ceiling value of $4,906.88. It is a delivery order contract with a firm fixed price pricing type, and the ultimate completion date is March 25, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite...